Could BELLUS HEALTH INC NEW COMMON SHARES (OTCMKTS:BLUSF) Go Down After Its Newest Short Interest Report?

May 18, 2018 - By Christine Reyes

BELLUS Health Inc. (OTCMKTS:BLUSF) Logo

The stock of BELLUS HEALTH INC NEW COMMON SHARES (OTCMKTS:BLUSF) registered a decrease of 54.84% in short interest. BLUSF’s total short interest was 1,400 shares in May as published by FINRA. Its down 54.84% from 3,100 shares, reported previously. With 17,800 shares average volume, it will take short sellers 0 days to cover their BLUSF’s short positions.

The stock increased 0.03% or $0.00015 during the last trading session, reaching $0.43245. About shares traded. BELLUS Health Inc. (OTCMKTS:BLUSF) has 0.00% since May 18, 2017 and is . It has underperformed by 11.55% the S&P500.

BELLUS Health Inc., a biopharmaceutical company, engages in developing novel therapeutics for conditions with high unmet medical need. The company has market cap of $50.14 million. The Company’s pipeline of projects include BLU-5937, a small molecule antagonist of the P2X3 receptor for chronic cough; KIACTA, a novel drug candidate for the treatment of patients suffering from active pulmonary sarcoidosis, a rare fatal inflammatory condition that affects the lungs; and Shigamab for the treatment of hemolytic uremic syndrome caused by Shiga toxin-producing E. coli. It currently has negative earnings. The firm also has economic interests in various other partnered drug development projects, including AMO-01 for Fragile X Syndrome and ALZ-801 for APOE4 homozygous Alzheimer's disease.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: